Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

32477

Supelco

Moxifloxacin hydrochloride

VETRANAL®, analytical standard

Sinonimo/i:

1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C21H24FN3O4· HCl
Numero CAS:
186826-86-8
Peso molecolare:
437.89
Beilstein:
8377447
Numero MDL:
MFCD00949117
Codice UNSPSC:
41116107
ID PubChem:
329754235
NACRES:
NA.24

Grado

analytical standard

Livello qualitativo

100

Nome Commerciale

VETRANAL®

Durata

limited shelf life, expiry date on the label

tecniche

HPLC: suitable
gas chromatography (GC): suitable

applicazioni

forensics and toxicology
pharmaceutical (small molecule)

Formato

neat

Temperatura di conservazione

2-8°C

Stringa SMILE

Cl.COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(O)=O

InChI

1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1
IDIIJJHBXUESQI-DFIJPDEKSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Applicazioni

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Note legali

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H302,H319,H412

Classi di pericolo

Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Irrit. 2

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 2

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Choose from one of the most recent versions:

Certificati d'analisi (COA)

Lot/Batch Number
BCCK5804
BCCK0171
BCCF3789
BCBZ3918
BCBR9420V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 8

1 of 8

Amikacin disulfate salt potency: 674-786 μg per mg (as amikacin base)

Sigma-Aldrich

A1774

Amikacin disulfate salt

Besifloxacin hydrochloride ≥98% (HPLC)

Sigma-Aldrich

SML1608

Besifloxacin hydrochloride

Ethionamide

Sigma-Aldrich

E6005

Ethionamide

vibrant-m

Y0002099

Moxifloxacin for peak identification A

Rifabutin >98% (HPLC), powder

Sigma-Aldrich

R3530

Rifabutin

Amikacin hydrate aminoglycoside antibiotic

Sigma-Aldrich

A3650

Amikacin hydrate

Amikacin sulfate salt aminoglycoside antibiotic

Sigma-Aldrich

A2324

Amikacin sulfate salt

Isoniazide analytical standard, ≥99% (TLC)

Supelco

I3377

Isoniazide

Cemile Banu Cosar et al.
European journal of ophthalmology, 24(3), 325-329 (2013-09-24)
To investigate refractive and visual outcomes and complications of the Supracor procedure to treat presbyopia. A total of 123 eyes from 68 presbyopic patients with hyperopia were enrolled in this prospective, nonrandomized, clinical trial. The Supracor procedure was performed using
Rohit Shetty et al.
BioMed research international, 2014, 340509-340509 (2014-10-11)
To report the profile of microbial keratitis occurring after corneal collagen cross-linking (CXL) in keratoconus patients. A retrospective analysis of 2350 patients (1715 conventional CXL, 310 transepithelial CXL, and 325 accelerated CXL) over 7 years (from January 2007 to January
Lingmin He et al.
JAMA ophthalmology, 133(1), 51-59 (2014-10-17)
Wavefront-guided (WFG) and wavefront-optimized (WFO) platforms for refractive surgery are designed for improved visual outcomes. It is unclear which treatment profile is superior for patients undergoing photorefractive keratectomy (PRK). To compare the safety, efficacy, predictability, stability, and higher-order aberrations in
Sumeet Khanduja et al.
Journal of glaucoma, 24(4), 267-271 (2013-01-23)
To evaluate the change in anterior chamber angle parameters after scleral buckling surgery using anterior segment optical coherence tomography (ASOCT). Fifty-five phakic eyes of 55 subjects undergoing scleral buckling with the placement of an encircling band for primary rhegmatogenous retinal
Lingmin He et al.
American journal of ophthalmology, 157(6), 1170-1178 (2014-02-25)
To compare the clinical outcomes of wavefront-guided and wavefront-optimized laser in situ keratomileusis (LASIK). Prospective, randomized, fellow-eye-controlled study. The setting was a single academic institution. The study population included 110 eyes of 55 patients with myopia with and without astigmatism.
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.